Tuesday, June 7, 2016

BRIEF-TG Therapeutics says first patient enrolled in UNITY-DLBCL phase 2b trial

* Announces first patient enrolled in registration-directed

UNITY-DLBCL phase 2b trial

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1 646 223 8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)